These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38869161)

  • 1. Epidemiology, diagnosis, and management of cardiac amyloidosis.
    Bashir Z; Younus A; Dhillon S; Kasi A; Bukhari S
    J Investig Med; 2024 Oct; 72(7):620-632. PubMed ID: 38869161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: state-of-the-art review.
    Bukhari S
    J Geriatr Cardiol; 2023 May; 20(5):361-375. PubMed ID: 37397865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid cardiomyopathy.
    Kristen AV
    Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and clinical manifestations of cardiac amyloidosis.
    Bajwa F; O'Connor R; Ananthasubramaniam K
    Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology.
    Stern LK; Grodin JL; Maurer MS; Ruberg FL; Patel AR; Khouri MG; Roth LR; Aras MA; Bhardwaj A; Bhattacharya P; Brailovsky Y; Drachman BM; Ebong IA; Fine NM; Gaggin H; Gopal D; Griffin J; Judge D; Kim P; Mitchell J; Mitter SS; Mohan RC; Ramos H; Reyentovich A; Sheikh FH; Sperry B; Carter S; Urey M; Vaishnav J; Vest AR; Kittleson MM; Patel JK
    J Card Fail; 2024 May; 30(5):669-678. PubMed ID: 37907148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E; López-Sainz Á; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Amyloidosis Treatment.
    Stern LK; Patel J
    Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging modalities in cardiac amyloidosis.
    Bashir Z; Musharraf M; Azam R; Bukhari S
    Curr Probl Cardiol; 2024 Dec; 49(12):102858. PubMed ID: 39299367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
    Narotsky DL; Castano A; Weinsaft JW; Bokhari S; Maurer MS
    Can J Cardiol; 2016 Sep; 32(9):1166.e1-1166.e10. PubMed ID: 27568874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
    J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
    Yamamoto H; Yokochi T
    ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
    Feldmann K; Hamm CW; Aßmus B
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Transthyretin Cardiac Amyloidosis: Unraveling the Complexities in Epidemiology, Pathophysiology, Diagnosis, and Treatment.
    Vilches S; Martínez-Avial M; Méndez I; Gómez González C; Espinosa MÁ
    Curr Heart Fail Rep; 2024 Aug; 21(4):344-353. PubMed ID: 38775878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
    Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
    ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis.
    Kwok CS; Moody WE
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231216318. PubMed ID: 38099406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.